Sudler & Hennessey started the ball rolling and soon other healthcare communications companies joined the effort to help the people of Haiti. So far they have raised over $100,000. To contribute, send email to Scott Cotherman: scott_cotherman@corbettaccel.com. For more information see the article by James Chase on MM&M's Web site.
January 2010 Archives
Interesting discussion on why corporate backing of medical research is NOT a bad thing:
Corporate Backing for Research? Get Over It!
John Tierney in the New York Times, Jan. 25, 2010
Hyperscrutiny of Academic-Industrial Relationships: Potential for Unintended Consequences
Tom Sullivan's Policy and Medicine Blog, Jan. 27, 2010
More thoughts on the issue on Tom Sullivan's Policy and Medicine Blog
Read about it and join the discussion here.
Corporate Backing for Research? Get Over It!
John Tierney in the New York Times, Jan. 25, 2010
Hyperscrutiny of Academic-Industrial Relationships: Potential for Unintended Consequences
Tom Sullivan's Policy and Medicine Blog, Jan. 27, 2010
More thoughts on the issue on Tom Sullivan's Policy and Medicine Blog
Read about it and join the discussion here.
First Amendment scholar Laurence Tribe provides thoughts on use of prescription data:
From WLF Legal Backgrounder, December 11, 2009 - Vol. 24, No. 40 --
A constitutional flu has taken hold in New England, and it threatens to spread throughout the country. New Hampshire, Maine, and Vermont have each recently enacted laws generally making it a crime to transfer entirely truthful information about prescriptions with the purpose of promoting prescription drugs. The point of these laws is neither to prevent misleading drug advertising or labeling nor to protect patient privacy -- other rules prohibit deceptive or otherwise unfair promotional practices and keep patients' identities confidential.
From WLF Legal Backgrounder, December 11, 2009 - Vol. 24, No. 40 --
A constitutional flu has taken hold in New England, and it threatens to spread throughout the country. New Hampshire, Maine, and Vermont have each recently enacted laws generally making it a crime to transfer entirely truthful information about prescriptions with the purpose of promoting prescription drugs. The point of these laws is neither to prevent misleading drug advertising or labeling nor to protect patient privacy -- other rules prohibit deceptive or otherwise unfair promotional practices and keep patients' identities confidential.
Continue reading The Fatal First Amendment Flaw In Prescription Restraint Statutes.
Visit the Health Central Web site for more information and resources for participation in the process:
Health Central
Health Central
